Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.

Mauro LoiTiziana ComitoCiro FranzeseLuca DominiciLorenzo Lo FaroElena ClericiDavide FranceschiniPietro MancosuGiacomo ReggioriPasqualina GalloMarco BadalamentiMarta Scorsetti

Published in: Journal of cancer research and clinical oncology (2020)

Delivery of ablative doses > 120 Gy10 and tumor size are determinants of LC. Prolonged PFS and improved OS can be obtained in BCLC A-B patients. Grade 3 liver dysfunction is infrequent.

Keyphrases

end stage renal disease
oxidative stress
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
squamous cell carcinoma
radiation induced